Wound healing improvement with PHD-2 silenced fibroblasts in diabetic mice.

BACKGROUND: Hypoxia-inducible factor 1α is the central regulator of the hypoxia-induced response which results in the up-regulation of angiogenic factors. Its activity is under precise regulation of prolyl-hydroxylase domain 2. We hypothesized that PHD2 silenced fibroblasts would increase the expres...

Full description

Bibliographic Details
Main Authors: Xiongliang Zhang, Xiaoyu Yan, Liang Cheng, Jiezhi Dai, Chunyang Wang, Pei Han, Yimin Chai
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3869847?pdf=render
id doaj-c229c5345af04f6f8c0cb7d4c8122b30
record_format Article
spelling doaj-c229c5345af04f6f8c0cb7d4c8122b302020-11-24T21:45:07ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01812e8454810.1371/journal.pone.0084548Wound healing improvement with PHD-2 silenced fibroblasts in diabetic mice.Xiongliang ZhangXiaoyu YanLiang ChengJiezhi DaiChunyang WangPei HanYimin ChaiBACKGROUND: Hypoxia-inducible factor 1α is the central regulator of the hypoxia-induced response which results in the up-regulation of angiogenic factors. Its activity is under precise regulation of prolyl-hydroxylase domain 2. We hypothesized that PHD2 silenced fibroblasts would increase the expression of angiogenic factors, which might contribute to the improvement of the diabetic wound healing. MATERIALS AND METHODS: 50 dB/db mice were employed and randomly assigned into five groups with 10 mice in each: group 1 (untreated cell), group 2 (PHD2 silenced cell), group 3 (L-mimosine treated cells), group 4 (nontargeting siRNA treated cells) and group 5 (sham control). Fibroblasts were cultivated from the dermis of mice in each group and treated with PHD2 targeting siRNA, L-mimosine and non-targeting siRNA respectively. A fraction of the fibroblasts were employed to verify the silencing rate of PHD2 after 48 hours. The autologous fibroblasts (treated and untreated) labeled with adenovirus-GFP were implanted around the wound (Φ6mm), which was created on the dorsum of each mouse. The status of wounds was recorded periodically. Ten days postoperatively, 3 mice from each group were sacrificed and wound tissues were harvested. Molecular biological examinations were performed to evaluate the expressions of cytokines. 28 days postoperatively, the remaining mice were sacrificed. Histological examinations were performed to evaluate the densities of GFP+ cells and capillaries. RESULTS: The expression of PHD2 reduced to 12.5%, and the expressions of HIF-1α and VEGFa increased significantly after PHD2 siRNA treatment. With the increasing expressions of HIF-1α and VEGFa, the time to wound closure in group 2 was less than 2 weeks. Increased numbers of GFP+ cells and capillaries were observed in group 2. CONCLUSION: PHD2 siRNA treatment not only increased the expression of HIF1α and VEGFa, but also improved the fibroblast proliferation. These effects might contribute to the improvement of the diabetic wound healing.http://europepmc.org/articles/PMC3869847?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Xiongliang Zhang
Xiaoyu Yan
Liang Cheng
Jiezhi Dai
Chunyang Wang
Pei Han
Yimin Chai
spellingShingle Xiongliang Zhang
Xiaoyu Yan
Liang Cheng
Jiezhi Dai
Chunyang Wang
Pei Han
Yimin Chai
Wound healing improvement with PHD-2 silenced fibroblasts in diabetic mice.
PLoS ONE
author_facet Xiongliang Zhang
Xiaoyu Yan
Liang Cheng
Jiezhi Dai
Chunyang Wang
Pei Han
Yimin Chai
author_sort Xiongliang Zhang
title Wound healing improvement with PHD-2 silenced fibroblasts in diabetic mice.
title_short Wound healing improvement with PHD-2 silenced fibroblasts in diabetic mice.
title_full Wound healing improvement with PHD-2 silenced fibroblasts in diabetic mice.
title_fullStr Wound healing improvement with PHD-2 silenced fibroblasts in diabetic mice.
title_full_unstemmed Wound healing improvement with PHD-2 silenced fibroblasts in diabetic mice.
title_sort wound healing improvement with phd-2 silenced fibroblasts in diabetic mice.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description BACKGROUND: Hypoxia-inducible factor 1α is the central regulator of the hypoxia-induced response which results in the up-regulation of angiogenic factors. Its activity is under precise regulation of prolyl-hydroxylase domain 2. We hypothesized that PHD2 silenced fibroblasts would increase the expression of angiogenic factors, which might contribute to the improvement of the diabetic wound healing. MATERIALS AND METHODS: 50 dB/db mice were employed and randomly assigned into five groups with 10 mice in each: group 1 (untreated cell), group 2 (PHD2 silenced cell), group 3 (L-mimosine treated cells), group 4 (nontargeting siRNA treated cells) and group 5 (sham control). Fibroblasts were cultivated from the dermis of mice in each group and treated with PHD2 targeting siRNA, L-mimosine and non-targeting siRNA respectively. A fraction of the fibroblasts were employed to verify the silencing rate of PHD2 after 48 hours. The autologous fibroblasts (treated and untreated) labeled with adenovirus-GFP were implanted around the wound (Φ6mm), which was created on the dorsum of each mouse. The status of wounds was recorded periodically. Ten days postoperatively, 3 mice from each group were sacrificed and wound tissues were harvested. Molecular biological examinations were performed to evaluate the expressions of cytokines. 28 days postoperatively, the remaining mice were sacrificed. Histological examinations were performed to evaluate the densities of GFP+ cells and capillaries. RESULTS: The expression of PHD2 reduced to 12.5%, and the expressions of HIF-1α and VEGFa increased significantly after PHD2 siRNA treatment. With the increasing expressions of HIF-1α and VEGFa, the time to wound closure in group 2 was less than 2 weeks. Increased numbers of GFP+ cells and capillaries were observed in group 2. CONCLUSION: PHD2 siRNA treatment not only increased the expression of HIF1α and VEGFa, but also improved the fibroblast proliferation. These effects might contribute to the improvement of the diabetic wound healing.
url http://europepmc.org/articles/PMC3869847?pdf=render
work_keys_str_mv AT xiongliangzhang woundhealingimprovementwithphd2silencedfibroblastsindiabeticmice
AT xiaoyuyan woundhealingimprovementwithphd2silencedfibroblastsindiabeticmice
AT liangcheng woundhealingimprovementwithphd2silencedfibroblastsindiabeticmice
AT jiezhidai woundhealingimprovementwithphd2silencedfibroblastsindiabeticmice
AT chunyangwang woundhealingimprovementwithphd2silencedfibroblastsindiabeticmice
AT peihan woundhealingimprovementwithphd2silencedfibroblastsindiabeticmice
AT yiminchai woundhealingimprovementwithphd2silencedfibroblastsindiabeticmice
_version_ 1725906557093281792